Prenatal factors and the development of asthma

Rajesh Kumar1

  • 1Division of Allergy and Immunology, Children's Memorial Hospital, Chicago, Illinois, USA. rkumar@childrensmemorial.org

Insights

Prenatal exposures like tobacco smoke and vitamin D levels significantly impact allergic diseases and early respiratory issues. Further research is needed to understand the mechanisms behind these early-life influences on childhood asthma.

Area of Science:

  • Environmental influences on health
  • Pediatric respiratory diseases
  • Allergic disease development

Background:

  • Prenatal and perinatal events are increasingly recognized as critical factors influencing allergic diseases and early-life respiratory morbidity.
  • Understanding these early-life exposures is crucial for preventing chronic respiratory conditions.

Purpose of the Study:

  • To review recent findings on prenatal exposures and their impact on allergic diseases and early-life respiratory health.
  • To explore potential mechanisms linking in-utero exposures to respiratory outcomes.

Main Methods:

  • Review of recent scientific literature and cohort studies published within the last year.
  • Analysis of epidemiological data on prenatal exposures and their correlation with respiratory and allergic outcomes.

Main Results:

  • In-utero exposures such as tobacco smoke, vitamin D levels, and prenatal infections modulate atopy and respiratory disease.
  • Gene-environment interactions, particularly with inflammatory pathway genes and smoke exposure, have been identified.
  • Prenatal endotoxin exposure may be protective, while chorioamnionitis combined with preterm birth may increase wheezing risk.

Conclusions:

  • Epidemiological evidence strongly supports multiple prenatal factors influencing early-life respiratory morbidity.
  • Mechanisms involving lung development, inflammation, and airway remodeling require further investigation.
  • The long-term impact of early-life wheezing risk factors on asthma development needs to be determined.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...